respondents support legalization, up from 33% in 2015
The #1to3 Campaign: Pushing for Federal Cannabis Reform
The #1to3 campaign is gaining momentum as it rallies Americans to pressure President Trump and Congress to reschedule marijuana from Schedule I to Schedule III. This move would have significant implications for the cannabis industry, including less tax burden for legitimate businesses, increased research opportunities, and a major step towards federal reform.
Take Action in Just 2 Minutes
The campaign urges supporters to take action in just 2 minutes by filling out NORML’s action form and flooding their representatives’ inboxes with messages demanding change. By making their voices heard, the people can show that they are watching and want this change now.
Trump Considers Rescheduling Marijuana
President Donald Trump recently stated that his administration is considering moving marijuana from Schedule I, the same category as heroin, to the less restrictive Schedule III. He also mentioned that a determination will be made in the next few weeks. This follows months of speculation and lobbying from the cannabis industry.
New Bill Introduced in Congress
The potential rescheduling of marijuana aligns with recommendations made by the Department of Health and Human Services last year and is reflected in a new bill introduced in Congress: the Marijuana 1-to-3 Act of 2025. This bill, filed by Rep. Greg Steube (R-FL), would direct the attorney general to move marijuana to Schedule III within 90 days of enactment.
Changing Attitudes in the GOP
Recent surveys have shown a shift in attitudes towards cannabis among Republican voters, with 43% now supporting legalization compared to 33% in 2015. This change in the GOP voter base could have a significant impact on the future of federal cannabis reform.
The Debate Continues
While the possibility of rescheduling marijuana is generating excitement among advocates, some are questioning the potential involvement of Big Pharma in shaping the future of cannabis. The recent presence of Pfizer CEO Albert Bourla at a dinner with Trump has raised concerns about the potential for a prescription-drug-only model for cannabis.
Join the #1to3 Campaign
Join the #1to3 campaign by posting the hashtag, tagging @realDonaldTrump, and contacting your representatives to show your support for federal cannabis reform. With the GOP voter base shifting and a new bill introduced in Congress, now is the time to push for change. Let your voice be heard and help make a difference in the future of cannabis.
